Another Antibody-Drug Conjugate Approved—Another on the Way for Breast Cancer
This month a Genentech (Roche) drug known as Polatuzumab vedotin-piiq (Polivy) was approved by the Food and Drug Administration (FDA). The drug, a CD79b-directed antibody-drug...
The Time is Now for Universal Adoption of Broader Clinical Trial Eligibility Criteria for...
Winship Cancer Institute of Emory University researchers conducted a retrospective study based on real-world data that revealed that if clinical sponsors expanded the inclusion...
First of its Kind Stem Cell Therapy Clinical Trials Led by Sanford Health in...
Sanford Health will participate in next cell therapy-based clinical trial using regenerative cells derived from adipose tissue. The cells are taken form the participant’s...
University of Nairobi, Kenya, AIDS Vaccine Initiative (KAVI) Launches Trial of New Vaccine that...
Kenya AIDS Vaccine Initiative (KAVI) is set to launch the clinical human trial of a vaccine that has the potential to stop HIV infecting...
CancerLinQ: The ASCO Subsidiary is Busy Supporting Increasing Amounts of Research
“Shoppers have Amazon. Students have Google. Oncologists will have CancerLinQ®"
The American Society of Clinical Oncology (ASCO) puts on an annual meting that has become...
Queens University Canada Led Research Probes Barriers for Physicians to Participate in Clinical Trials
Canadian researchers led by physicians from Queen’s University, Ontario, conducted a study probing into the barriers physicians face to successfully participate in clinical trials.
The...
EDC Leader Medidata Acquired by French Medidata Solutions
Medidata Solutions has been acquired for $5.8 billion on approximately $660mi in revenue for a significant multiple on revenues. TrialSite News discussed this potential acquisition...
A Salesforce-based Clinical Trial Enrollment System Powers Improved Clinical Trial Velocity at an Elite...
TrialSite News recently covered UCSF’s configuration of Salesforce for a patient enrollment system.
TrialSite News staff interview Robert Krumm, an application developer for University of...
- Advertisement -